Lacosamide

Lacosamide, the active ingredient in Lacosamide, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of partial seizures in patients with epilepsy, helping to reduce seizure frequency.

GNH USA supplies Lacosamide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for qualified healthcare providers. The company adheres to stringent quality standards and offers comprehensive regulatory support for global distribution. All batches are manufactured under GMP conditions and undergo rigorous testing to ensure purity and potency.

Lacosamide is an anticonvulsant used to manage seizure disorders.

Partial-onset seizures: reduces seizure frequency as adjunctive therapy. Focal epilepsy: helps control focal seizure activity when added to other antiepileptic drugs. Secondary generalization: lowers risk of seizure spread in patients with partial-onset seizures.

Lacosamide may cause a range of adverse reactions.

Common Side Effects: - Dizziness: sensation of light‑headedness or imbalance. - Nausea: upset stomach or urge to vomit. - Headache: mild to moderate pain in the head. - Fatigue: feeling unusually tired or weak. - Blurred vision: temporary visual disturbances. - Diplopia: double vision.

Serious or Rare Side Effects: - Cardiac conduction abnormalities: PR‑interval prolongation or arrhythmia. - Suicidal ideation: thoughts of self‑harm requiring immediate evaluation. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hypersensitivity: rash, itching, or anaphylactic response. - Hepatic enzyme elevation: significant increase in liver function tests. - Status epilepticus: worsening seizure activity requiring urgent care.

Before initiating therapy, consider the following precautions.

Renal impairment: adjust dosing and monitor renal function. Hepatic impairment: use caution and monitor liver enzymes. Cardiac conduction disorders: obtain baseline ECG and monitor PR interval. Pregnancy: risk unknown; prescribe only if benefit outweighs potential risk. Concomitant CNS depressants: monitor for enhanced sedation or respiratory depression. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lacosamide can interact with several medications.

Major Interactions (Avoid): - Strong CYP3A4 inducers: may reduce lacosamide plasma concentrations. - Drugs that prolong PR interval (e.g., class IA antiarrhythmics): increase risk of cardiac conduction effects. - Other sodium‑channel blockers: may amplify central nervous system adverse effects.

Moderate Interactions (Monitor Closely): - Carbamazepine: can increase lacosamide levels, requiring dose adjustment. - Phenytoin: may affect metabolism and alter therapeutic response. - Alcohol: can enhance dizziness and sedation, necessitating caution.